case_images: PMC11319052_01
case_images: Inverse Gottron's papules in MDA 5 DM.
case_images: CRIRH2024-7410630.001.jpg
case_images: PMC11319052_01_CRIRH2024-7410630.001.jpg
case_images: fig1
case_images: Inverse Gottron's papules, commonly associated with anti-MDA 5 DM, were present (Figure 1).
case_images: GAVE in MDA 5 DM.
case_images: CRIRH2024-7410630.002.jpg
case_images: PMC11319052_01_CRIRH2024-7410630.002.jpg
case_images: fig2
case_images: A gastroscopy was done for dysphagia and revealed a watermelon stomach as depicted in Figure 2.
case_images: PMC11319052_02
case_images: Hypopigmented Gottron's papules in TIF1y DM.
case_images: CRIRH2024-7410630.003.jpg
case_images: PMC11319052_02_CRIRH2024-7410630.003.jpg
case_images: fig3
case_images: A 30-year-old African woman presented in 2020 with a heliotrope rash, facial photosensitive rash, shawl sign, v sign, truncal poikiloderma, sleeve sign, hypopigmented Gottron's papules (Figure 3), calcinosis, and a specific sign called red on white patch (Figure 4).
case_images: Red on white patch in TIF1y DM.
case_images: CRIRH2024-7410630.004.jpg
case_images: PMC11319052_02_CRIRH2024-7410630.004.jpg
case_images: fig4
case_images: A 30-year-old African woman presented in 2020 with a heliotrope rash, facial photosensitive rash, shawl sign, v sign, truncal poikiloderma, sleeve sign, hypopigmented Gottron's papules (Figure 3), calcinosis, and a specific sign called red on white patch (Figure 4).
case_images: PMC11319052_03
case_images: Acute Gottron's papules in SRP DM.
case_images: CRIRH2024-7410630.005.jpg
case_images: PMC11319052_03_CRIRH2024-7410630.005.jpg
case_images: fig5
case_images: At presentation, he already had significant quadriceps atrophy and overt splinter hemorrhages (Figure 5).
case_images: Splinter hemorrhages in SRP DM.
case_images: CRIRH2024-7410630.006.jpg
case_images: PMC11319052_03_CRIRH2024-7410630.006.jpg
case_images: fig6
case_images: No skin rash was observed on admission; however, within a month of admission, he had developed Gottron's papules (Figure 6).